The Baltimore Sun welcomes submissions of op-ed articles of 650 to 750 words. Local topics and authors are preferred. Please submit them by using this form or emailing commentary@baltsun.com.

The Sun welcomes comments from readers via letters to the editor. All comments become the property of The Sun, which reserves the right to edit them. To submit a letter to the editor, use the form ...

The Star-Advertiser welcomes letters up to 150 words and guest columns of 500-600 words. The Star-Advertiser reserves the right to edit letters for clarity and length. Please direct comments to the ...

The Post welcomes letters up to 250 words on topics of general interest. Letters must include full name, home address, day and evening phone numbers, and may be edited for length, grammar and accuracy ...

A workflow software provider for the National Health Service (NHS) England has confirmed that it suffered a cyber attack that impacted its internal systems.

An Australian company involved in gold and phosphate mining has been listed on the dark web, with contracts and ...

Email, call 303-954-1201, or text 720-663-9316 Go back Your message has been sent News Tip(required) Warning If you would like a reply, include your email Warning Warning. Submit Δ ...

Several users of the Trust Wallet Chrome extension report having their cryptocurrency wallets drained after installing a ...

The New York Times looks for intelligent, literate, entertaining and well-crafted crosswords that appeal to the broad range of Times solvers. Submissions are now closed on our submission platform, ...

Form 2441 is used for claiming child and dependent care expenses Investopedia / Zoe Hansen IRS Form 2441 calculates the amount of the Child and Dependent Care tax credit an eligible family can claim ...

If electors fail to submit the enumeration forms, distributed as part of the ongoing Special Intensive Revision (SIR) of the electoral rolls, before December 4, their names will not feature in the ...

Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in ...